Raymond James Trust N.A. Biogen Inc. Transaction History

Raymond James Trust N.A.

  • $4.22 Billion
  • Q2 2024

A detailed history of Raymond James Trust N.A. transactions in Biogen Inc. stock. As of the latest transaction made, Raymond James Trust N.A. holds 2,913 shares of BIIB stock, worth $569,870. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,913
Previous 2,968 1.85%
Holding current value
$569,870
Previous $639,000 5.63%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$190.52 - $236.72 $10,478 - $13,019
-55 Reduced 1.85%
2,913 $675,000
Q1 2024

Apr 24, 2024
BUY
$212.02 - $267.71 $73,994 - $93,430
349 Added 13.33%
2,968 $639,000
Q4 2023

Jan 10, 2024
SELL
$222.59 - $267.94 $18,474 - $22,239
-83 Reduced 3.07%
2,619 $677,000
Q3 2023

Nov 14, 2023
BUY
$253.3 - $285.89 $11,905 - $13,436
47 Added 1.77%
2,702 $694,000
Q2 2023

Aug 15, 2023
BUY
$275.25 - $318.06 $10,184 - $11,768
37 Added 1.41%
2,655 $757,000
Q1 2023

May 03, 2023
SELL
$256.56 - $292.34 $34,122 - $38,881
-133 Reduced 4.83%
2,618 $728,000
Q4 2022

Feb 02, 2023
SELL
$252.44 - $306.72 $27,263 - $33,125
-108 Reduced 3.78%
2,751 $762,000
Q3 2022

Oct 31, 2022
SELL
$194.69 - $268.46 $17,911 - $24,698
-92 Reduced 3.12%
2,859 $764,000
Q2 2022

Jul 14, 2022
SELL
$187.54 - $223.02 $64,326 - $76,495
-343 Reduced 10.41%
2,951 $602,000
Q1 2022

May 12, 2022
BUY
$193.77 - $244.14 $89,909 - $113,280
464 Added 16.4%
3,294 $693,000
Q4 2021

Jan 31, 2022
SELL
$223.92 - $287.77 $58,443 - $75,107
-261 Reduced 8.44%
2,830 $679,000
Q3 2021

Oct 18, 2021
BUY
$282.99 - $369.05 $82,350 - $107,393
291 Added 10.39%
3,091 $875,000
Q2 2021

Jul 20, 2021
SELL
$259.0 - $414.71 $1,554 - $2,488
-6 Reduced 0.21%
2,800 $970,000
Q1 2021

May 03, 2021
SELL
$242.95 - $284.63 $61,709 - $72,296
-254 Reduced 8.3%
2,806 $785,000
Q4 2020

Jan 13, 2021
SELL
$236.26 - $355.63 $12,521 - $18,848
-53 Reduced 1.7%
3,060 $749,000
Q3 2020

Oct 14, 2020
SELL
$264.77 - $305.71 $73,870 - $85,293
-279 Reduced 8.23%
3,113 $883,000
Q2 2020

Jul 16, 2020
SELL
$258.66 - $342.55 $191,408 - $253,487
-740 Reduced 17.91%
3,392 $907,000
Q1 2020

Apr 17, 2020
SELL
$268.85 - $341.04 $289,551 - $367,300
-1,077 Reduced 20.68%
4,132 $1.31 Million
Q4 2019

Jan 14, 2020
SELL
$220.06 - $304.07 $180,669 - $249,641
-821 Reduced 13.62%
5,209 $1.55 Million
Q3 2019

Oct 24, 2019
BUY
$217.44 - $243.88 $109,807 - $123,159
505 Added 9.14%
6,030 $1.4 Million
Q2 2019

Jul 15, 2019
SELL
$219.29 - $241.72 $30,262 - $33,357
-138 Reduced 2.44%
5,525 $1.29 Million
Q1 2019

Apr 15, 2019
SELL
$216.71 - $338.96 $158,415 - $247,779
-731 Reduced 11.43%
5,663 $1.34 Million
Q4 2018

Jan 29, 2019
SELL
$278.5 - $352.75 $82,157 - $104,061
-295 Reduced 4.41%
6,394 $1.92 Million
Q3 2018

Oct 16, 2018
BUY
$293.51 - $383.83 $208,979 - $273,286
712 Added 11.91%
6,689 $2.36 Million
Q2 2018

Jul 11, 2018
BUY
$257.52 - $306.91 $145,498 - $173,404
565 Added 10.44%
5,977 $1.74 Million
Q1 2018

Apr 05, 2018
BUY
$260.13 - $367.91 $50,205 - $71,006
193 Added 3.7%
5,412 $1.48 Million
Q4 2017

Feb 02, 2018
BUY
$307.64 - $344.58 $172,278 - $192,964
560 Added 12.02%
5,219 $1.66 Million
Q3 2017

Oct 24, 2017
SELL
$281.15 - $329.69 $15,182 - $17,803
-54 Reduced 1.15%
4,659 $1.46 Million
Q2 2017

Aug 10, 2017
BUY
N/A
4,713
4,713 $1.28 Million

Others Institutions Holding BIIB

# of Institutions
1,050
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $28.2B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Raymond James Trust N.A. Portfolio

Follow Raymond James Trust N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Trust N.A., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Trust N.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email